REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re NAV and Interim Dividend

23 Jul 2015 16:25

RNS Number : 9493T
Maven Income and Growth VCT 5 PLC
23 July 2015
 



 

Maven Income and Growth VCT 5 PLC

 

Net Asset Value and Interim Dividend

 

The Directors of Maven Income and Growth VCT 5 PLC (the Company) confirm that the unaudited net asset value of the Company as at 31 May 2015 was 41.67p per Ordinary Share, prior to the payment, on 5 June 2015, of the final dividend of 1.7p per share in respect of the year ended 30 November 2014.

 

The Directors declare that an interim dividend of 0.9p per Ordinary Share, in respect of the six months ended 31 May 2015 (2014: 0.8p), will be paid on 28 August 2015 to Shareholders on the register at close of business on 31July 2015. 

 

The Company operates a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to subscribe for additional Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Subject to a Shareholder's individual circumstances and related investment limits, new shares issued under the DIS will qualify for the VCT tax reliefs applicable for the tax year in which they are allotted.

 

Shareholders wishing to take advantage of the DIS for the interim dividend in respect of the six months ended 31 May 2015 should ensure that a mandate or CREST instruction is in place by no later than the election date of 14 August 2015. For certificated Shareholders, once submitted, a mandate form will remain valid for all subsequent dividends paid by the Company until such time as the Shareholder gives notice that they no longer wish to participate in the DIS. CREST participants must elect in respect of each dividend, otherwise they will receive the payment in cash. Full details of the DIS and a mandate form are available on the Company's website at: www.mavencp.com/migvct5.

 

However, in light of the investment restrictions proposed in the Government's Summer 2015 Budget, the Directors intend to review the operation of the DIS and reserve the right, under the Terms and Conditions of the Scheme, to suspend or terminate its operation without notice and revert to cash payments to all Participants.

 

In accordance with Listing Rule 15.5.1, and further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Section 118C of the Financial Services and Markets Act 2000) that the Directors and the Company may have in their possession relating to the Company during the period leading up to the announcement of its interim results for the six months ended 31 May 2015 has been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

23 July 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFFEDEIVFIE
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.